Work

Abstract PS2-04-23: Poor response to systemic therapy upon progression on cyclin dependent kinase 4/6 inhibitors in HR+ Inflammatory Breast Cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-04-23

Authors: A. Nasrazadani, M. Kai, R. Tidwell, B. Lim, V. Valero, R. Layman, The MDACC Inflammatory Breast Cancer Team, W. Woodward

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130751696

Cites:

Cited by:

Related to: